Cyn3rgy
  • Home
  • About
    • Getting Involved >
      • ONYCHOMYCOSIS OF THE TOENAIL FUNGUS
      • SCABIES
      • ACNE_landing
      • ADHD
      • SKIN STRUCTURAL INFECTIONS
      • CONSTIPATION
      • ATOPIC DERMATITIS
      • MOLLUSCUM CONTAGIOSUM
      • OVERACTIVE BLADDER
      • EAR INFECTIONS
      • PNEUMOCOCCAL DISEASE
      • DIAGNOSTIC SAMPLE STUDIES
      • CORONAVIRUS CLINICAL TRIALS
  • Contact
  • Privacy Policy
Picture
Study 1: A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis.

Study 2: A Prospective, observational, longitudinal study in pediatric patients with moderate to severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not medically advisable.


 For more information, call
Cyn3rgy Research at
​503 907 2179 x3
Sign Up for one of our studies!
    Your email will not be shared with any other companies. 
Submit

We Would Love to hear from you!

Hours

Address: Cyn3rgy Research
23331 SE Stark St. Suite 201b
Gresham, OR 97030

Business Hours: 
Monday - Thursday, 8:00 am - 5:30 pm
Friday - Per scheduled appointment.
If you have tested positive for COVID within 7 days and are coming in for an appointment, please wear a mask and notify a member of our study team prior to, or upon arrival. Thank you.

Email

support@cyn3rgy.com

Telephone

503-907-2179



Picture
  • Home
  • About
    • Getting Involved >
      • ONYCHOMYCOSIS OF THE TOENAIL FUNGUS
      • SCABIES
      • ACNE_landing
      • ADHD
      • SKIN STRUCTURAL INFECTIONS
      • CONSTIPATION
      • ATOPIC DERMATITIS
      • MOLLUSCUM CONTAGIOSUM
      • OVERACTIVE BLADDER
      • EAR INFECTIONS
      • PNEUMOCOCCAL DISEASE
      • DIAGNOSTIC SAMPLE STUDIES
      • CORONAVIRUS CLINICAL TRIALS
  • Contact
  • Privacy Policy